Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Penfluridol
Cat. No.:
OB0225LY-0312
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Penfluridol is an antipsychotic reagent used primarily in studies affecting the central nervous system.
Synonym:
R-16341; TLP-607; 26864-56-2; Semap; 1-(4,4-Bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol; Penfluridolum; 1- 1-[4,4-Bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
CAS No.:
26864-56-2
Compound CID:
33630
Formula:
C28H27ClF5NO
Formula Weight:
523.97
Specification
Relative Density:
1.2425 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Penfluridol can be used to study key mechanisms in the fields of mental health and neurobiology.
Library Information
Targets:
Dopamine receptor; Calcium channel
Pathways:
Metabolism; Membrane transporter/Ion channel; Autophagy; Neuronal signaling; GPCR/G protein
Plate Number:
AOCL-5
Plate Location:
a5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
93 mg/mL; 177.5 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
93 mg/mL; 177.5 mM
